Oncology Nurse Helps Patients Be Brave

Article

An oncology nurse started a grassroots campaign that brought together community members and patients on the oncology unit.

After being inspired by one of her patients, Harding Cranford, RN, OCN, an oncology nurse at the Levine Cancer Institute, wanted a way to connect the community with the patients she treated on the oncology unit.

So, the nurse started "Bravery Bags," a program where people can donate items to those going through cancer that can act as a pick-me-up during treatment. What started as a small grassroots campaign spanned into donations coming from across the nation, brightening the days of hundreds of patients.

Read more: Educating the Community While Helping Patients With Cancer

Recent Videos
Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC in an interview with oncology nursing news
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Elizabeth Burton in an interview with Oncology Nursing News
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
green background with blue text saying FDA

FDA Approves Encorafenib Plus Cetuximab and Chemo in BRAF V600E-Positive Metastatic CRC

Chris Ryan
Published: December 20th 2024 | Updated: December 20th 2024
Article

The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of metastatic colorectal cancer harboring a BRAF V600E mutation.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

Treatment sequencing

Real-World Evaluates Treatment Sequencing Optimization in CLL/SLL

Jordyn Sava
December 20th 2024
Article

Treatment sequencing with targeted therapies may help to improve overall survival, according to real-world data.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Myeloma

Isatuximab Quadruplet Yields Rapid, Deep Responses in Newly Diagnosed Myeloma

Silas Inman
December 19th 2024
Article

Initial therapy with isatuximab plus VRd followed by its addition to Rd maintenance therapy led to significantly improved MRD negativity and PFS in transplant-ineligible multiple myeloma.

lung cancer

Rx Road Map: Amivantamab (Rybrevant) Plus Lazertinib (Lazcluze)

Denise Rouse, MMS, PA-C;Margaret Colleton, MMS, MSW, PA-C
December 19th 2024
Article

APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.

© 2024 MJH Life Sciences

All rights reserved.